[1]宋祯彦,何攀,李富周,等.高效液相色谱串联质谱法测定当归芍药散提取物和含药血清中3种活性成分含量[J].中国中医药信息杂志,2021,28(1):92-99.[doi:10.19879/j.cnki.1005-5304.202005099]
 SONG Zhenyan,HE Pan,LI Fuzhou,et al.Content Determination of Three Active Components in Danggui Shaoyao Powder Extracts and Its Drug-containing Serum by HPLC-MS/MS[J].zhongguo zhongyiyao xinxi zazhi,2021,28(1):92-99.[doi:10.19879/j.cnki.1005-5304.202005099]
点击复制

高效液相色谱串联质谱法测定当归芍药散提取物和含药血清中3种活性成分含量

参考文献/References:

[1] 李佳曦,贾淑琳,瞿融.近三年当归芍药散实验及临床研究进展[J].江西中医药,2008,39(9):58-60.

[2] 刘敏,任存霞.当归芍药散的实验研究进展[J].中医药学报,2019, 47(5):117-119.

[3] 鄢胜君,操燕明.当归芍药散治疗原发性痛经研究进展[J].中药药理与临床,2020,36(1):243-248.

[4] 陈湘宜,胡欣欣.当归芍药散加味治疗盆腔炎患者的临床效果[J].中华全科医学,2020,18(2):255-257,261.

[5] 苏浩武.当归芍药散治疗湿瘀互结证慢性肾小球肾炎患者的临床效果观察[J].中医临床研究,2020,12(5):133-135.

[6] 常亚利.当归芍药散治疗黄褐斑临床观察[J].实用中医药杂志,2020, 36(3):285-286.

[7] 余婧萍,贺春香,成绍武,等.当归芍药散通过调控NF-κB炎性通路改善H2O2诱导的SH-SY5Y细胞氧化损伤的作用[J].中国实验方剂学杂志,2020,26(10):1-7.

[8] 宋祯彦,陈易璇,余婧萍,等.当归芍药散活性成分治疗阿尔兹海默病作用机制的生物网络分析[J].世界科学技术-中医药现代化,2018, 20(6):834-846.

[9] 刘艳娜.当归芍药散的组方和药理药效研究[J].世界最新医学信息文摘,2017,17(17):102.

[10] ZHANG L, WEI W. Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony[J]. Pharmacology and Therapeutics,2020,207:107452.

[11] ZHAI A, ZHANG Z, KONG X J. Paeoniflorin alleviates H2O2-induced oxidative injury through down-regulation of microRNA-135a in HT-22 cells[J]. Neurochem Res,2019,44(12):28212831.

[12] SALAU V F, ERUKAINURE O L, IBEJI C U, et al. Ferulic acid modulates dysfunctional metabolic pathways and purinergic activities, while stalling redox imbalance and cholinergic activities in oxidative brain injury[J]. Neurotox Res,2020, 37(4):944955.

[13] DIEGO L, IVAN L, LICETH C M, et al. Maize extract rich in ferulic acid and anthocyanins prevents high-fat-induced obesity in mice by modulating SIRT1, AMPK and IL-6 associated metabolic and inflammatory pathways[J]. J Nutr Biochem,2020,79:108343.

[14] 杜雪蓓,燕灏敏,梁津瑜,等.阿魏酸钠对慢性脑低灌注大鼠认知功能及对磷酸化ERK、CREB和BDNF表达的影响[J].武汉大学学报(医学版),2017,38(5):713-718.

[15] PANG Y, ZHU S, PEI H. Pachymic acid protects against cerebral ischemia/reperfusion injury by the PI3K/Akt signaling pathway[J]. Metab Brain Dis,2020,35(4):673-680.

[16] 陈伟光,张学峰,官莹,等.茯苓酸对小鼠病毒性心肌炎Caspase-3及Akt表达的相关研究[J].心脑血管病防治,2019,19(6):501-503,519,593.

[17] WANG C F, FENG L, MA L, et al. Alisol A 24-acetate and alisol B 23-acetate induced autophagy mediates apoptosis and nephrotoxicity in human renal proximal tubular cells[J]. Front Pharmacol,2017,8:172.

[18] LI Y X, WANG Y P, LIU Z X, et al. Atractylenolide I induces apoptosis and suppresses glycolysis by blocking the JAK2/STAT3 signaling pathway in colorectal cancer cells[J]. Front Pharmacol, 2020,11:273.

[19] ZHOU X, REN Q, WANG B, et al. Alisol A 24-acetate isolated from the alismatis rhizoma improves hepatic lipid deposition in hyperlipidemic mice by ABCA1/ABCG1 pathway[J]. J Nanosci Nanotechnol,2019,19(9):5496-5502.

[20] 付新,张洪财,张贺,等.HPLC测定当归芍药散中的芍药苷和芍药内酯苷的含量[J].化学工程师,2020,34(1):25-27.

[21] 贺晓艳,宋秋月,郑丹,等.HPLC法测定当归芍药散中芍药苷、白芍苷、阿魏酸、洋川芎内酯Ⅰ的含量[J].亚太传统医药,2011,7(7):36-39.

[22] 饶怡菲,江志辉,何明珍,等.基于超高效液相色谱-串联质谱法研究宽缨酮在大鼠体内的生物利用度及代谢产物[J].中药新药与临床药理,2020,31(4):455-463.

[23] LIU B, SONG Z, YU J, et al. The atherosclerosis-ameliorating effects and molecular mechanisms of BuYangHuanWu decoction[J]. Biomed Pharmacother,2020,123:109664.

[24] 林朝展,李宝晶,韩立炜.从近5年国家自然科学基金资助项目浅谈中药质量评价研究现状[J].中草药,2020,51(2):281-286.

[25] 彭国梅,张启云,李冰涛,等.UPLC-MS/MS同时测定葛根芩连汤含药血清10个有效成分的含量[J].中药新药与临床药理,2016,27(3):393- 398.

[26] 闫寒,付衍,彭娟,等.大鼠含药血清中芍药苷的含量测定[J].中国实验方剂学杂志,2013,19(14):89-91.

[27] 杨慧敏,杨彪,胡玉梅,等.基于UPLC-ESI-Q-TOF-MS/MS 技术的桂枝茯苓胶囊化学成分分析[J].中国中药杂志,2020,45(4):861-877.

[28] 张莉野,田成旺,刘素香,等.桂枝茯苓方的化学成分、药理作用及质量标志物(Q-marker)的预测分析[J].中草药,2019,50(2):265-272.

[29] 梁乙川,伍清芳,刘素娟,等.HPLC法同时测定川芎药材中10种成分含量[J].中药材,2019,42(1):136-138.

[30] 荀秀彪,张顺平.HPLC同时测定归芍疏肝散中芍药苷阿魏酸和甘草酸铵的含量[J].中国现代中药,2020,22(2):278-281.

相似文献/References:

[1]高家荣,魏良兵,韩燕全,等.复方枣仁安神胶囊质量控制研究[J].中国中医药信息杂志,2010,17(7):57.[doi:10.3969/j.issn.1005-5304.2010.07.023]
 GAO Jia-rong,WEI Liang-bing,HAN Yan-quan,et al.Study on Quality Control of Fufang Zaoren Anshen Capsule[J].zhongguo zhongyiyao xinxi zazhi,2010,17(1):57.[doi:10.3969/j.issn.1005-5304.2010.07.023]
[2]许巧霞,杜平,苏叶萍,等.大孔吸附树脂分离纯化青番茄中的番茄苷[J].中国中医药信息杂志,2010,17(8):51.[doi:10.3969/j.issn.1005-5304.2010.08.024]
 XU Qiao-xia,DU Ping,SU Ye-ping,et al.Separation and Purification of Tomatine in Green Tomatoes with Macroporous Adsorption Resin[J].zhongguo zhongyiyao xinxi zazhi,2010,17(1):51.[doi:10.3969/j.issn.1005-5304.2010.08.024]
[3]马丽君,苗珍花,马伟,等.阿魏酸和芍药苷混合剂对PC12细胞损伤的影响[J].中国中医药信息杂志,2009,16(2):36.
 MA Li-jun,MIAO Zhen-hua,MA Wei,et al.Effects of the Mixture of Ferulic Acid and Paeoniflorin on PC12 Cells Injury[J].zhongguo zhongyiyao xinxi zazhi,2009,16(1):36.
[4]孟静娟,单风平.反相高效液相色谱法测定接骨胶囊中阿魏酸的含量[J].中国中医药信息杂志,2009,16(4):41.
 MENG Jing-juan,SHAN Feng-ping.Determination of Ferulic Acid in Jiegu Capsule by RP-HPLC[J].zhongguo zhongyiyao xinxi zazhi,2009,16(1):41.
[5]魏元锋,张宁,冯怡.HPLC-DAD法同时测定大川芎复方释药系统中阿魏酸与天麻素的含量[J].中国中医药信息杂志,2009,16(7):46.
 WEI Yuan-feng,ZHANG Ning,FENG Yi.Determination of Ferulic Acid and Gastrodin in Drug Delivery System of Dachuanxiong by HPLC/DAD[J].zhongguo zhongyiyao xinxi zazhi,2009,16(1):46.
[6]蔡俊安.当归养血丸中阿魏酸的HPLC测定[J].中国中医药信息杂志,2011,18(4):47.[doi:10.3969/j.issn.1005-5304.2011.04.019]
 CAI Jun-an.Determination of Ferulic Acid in Danggui Yangxue Wan by HPLC[J].zhongguo zhongyiyao xinxi zazhi,2011,18(1):47.[doi:10.3969/j.issn.1005-5304.2011.04.019]
[7]翁燕,刘志辉.痛经合剂质量标准研究[J].中国中医药信息杂志,2011,18(8):52.[doi:10.3969/j.issn.1005-5304.2011.08.021]
 WENG Yan,LIU Zhi-hui.Study on Quality Standard of Tongjing Mixture[J].zhongguo zhongyiyao xinxi zazhi,2011,18(1):52.[doi:10.3969/j.issn.1005-5304.2011.08.021]
[8]庄志宏,毛克臣,陈志峰,等.硫磺熏蒸前后当归中阿魏酸含量的比较研究[J].中国中医药信息杂志,2011,18(8):60.[doi:10.3969/j.issn.1005-5304.2011.08.024]
 ZHUANG Zhi-hong,MAO Ke-chen,CHEN Zhi-feng,et al.Comparative Study of Sulfur Fumigation on Ferulic Acid Contents in Radix angelicae sinensis[J].zhongguo zhongyiyao xinxi zazhi,2011,18(1):60.[doi:10.3969/j.issn.1005-5304.2011.08.024]
[9]范彬,石晓峰,马趣环,等.安乳颗粒质量标准研究[J].中国中医药信息杂志,2011,18(11):55.[doi:10.3969/j.issn.1005-5304.2011.11.022]
 FAN Bin,SHI Xiao-feng,MA Qu-huan,et al.Study on Quality Standard for Anru Granules[J].zhongguo zhongyiyao xinxi zazhi,2011,18(1):55.[doi:10.3969/j.issn.1005-5304.2011.11.022]
[10]程立方,崔秀君.产舒康颗粒质量控制研究[J].中国中医药信息杂志,2007,14(6):43.
 CHENG Li-fang,CUI Xiu-jun.Quality Control for Chanshukang Granule[J].zhongguo zhongyiyao xinxi zazhi,2007,14(1):43.

备注/Memo

基金项目:国家自然科学基金(81774129、82004184);湖南省自然科学基金面上项目(2018JJ2296);湖南省自然科学基金青年基金(2019JJ50441);湖南省高校创新平台开放基金项目(19K065);湖南省教育厅科学研究项目(18B246);湖南创新型省份建设专项(2019RS1064)

更新日期/Last Update:

2020-12-18